4579 — RaQualia Pharma Balance Sheet
0.000.00%
Last trade - 00:00
- ¥13bn
- ¥10bn
- ¥2bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,200 | 2,114 | 2,659 | 3,926 | 3,765 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 747 | 531 | 1,205 | 602 | 603 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,067 | 2,834 | 4,004 | 4,822 | 4,957 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 249 | 333 | 299 | 391 | 574 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 4,837 | 4,251 | 5,234 | 6,258 | 6,872 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 183 | 187 | 401 | 494 | 389 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 216 | 240 | 446 | 761 | 752 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 4,621 | 4,011 | 4,788 | 5,497 | 6,120 |
Total Liabilities & Shareholders' Equity | 4,837 | 4,251 | 5,234 | 6,258 | 6,872 |
Total Common Shares Outstanding |